Back To Search Results

Rectal Cancer Microsurgery

Editor: Saran Lotfollahzadeh Updated: 8/14/2023 9:31:31 PM

Introduction

Colorectal malignancies are considered the third most common cancer for both male and female individuals. Moreover, they are the second most common cause of malignancy-related mortalities in the United States.[1] However, it should be noted that the distinct rectal cancer prevalence might not be simply concluded from the current cancer registry and is mostly combined with colon cancer data sets.[2]

Histological diagnosis of invasive adenocarcinoma should be confirmed before surgical planning for rectal cancers because in the management of rectal neoplasms of other histologies, including squamous cell carcinomas, non-surgical or different multimodality options are indicated.[3]

Operative management with excisional biopsy is typically not indicated unless it is feasible to perform with adequate radial margins and curative intentions. Local excision in the management of rectal cancer is an acceptable surgical option with curative intent and is limited to the highly selected patients with cT1N0. Moreover, the patient should have favorable clinical and histological characteristics. Accordingly, transanal excision may be indicated in patients with more advanced cT disease who do not meet the eligibility criteria for radical cancer surgery.[4][5]

Local excision in treating rectal cancers provides several advantages, including limited operative risk and minimal functional morbidities. However, it does not adequately excise the tumor, and the mesorectal lymph nodes' pathological staging is less than optimal.[6]

Determining the exact depth of tumoral invasion (Tis, T1, or T2) may be complicated using MRI only. Therefore, endoscopic ultrasonography (EUS) may be applied as a complementary tool for more precise staging.[7]

The optimal approach for managing rectal adenocarcinoma depends on several factors, of which the tumor location in the rectum and tumoral extension are the most important. The surgical approach remains the only curative treatment for rectal cancer. Curative resection demands a wide resection with histologically negative margins and total mesorectal excision (TME). Total mesorectal excision includes local lymph node resection via transabdominal approach. The trans-abdominal approach in the management of rectal cancer refers to low anterior resection or abdominoperineal resection.[8]

Rectal microsurgery is a form of minimally invasive surgery used in the treatment of early rectal cancers, defined as an adenocarcinoma invading the rectal wall up to the submucosa.[4] Traditionally, rectal resection combined with total mesenteric excision (TME) was the gold standard for all rectal cancers.[9] Unfortunately, this procedure is associated with high morbidity and functional sequelae, which may not be considered acceptable in early disease.

Transanal excision (TAE) using a conventional retractor was one method of managing benign neoplasia and early rectal cancer. This technique is significantly limited by exposure and visibility, making it incredibly difficult to achieve high-quality oncological resections. High lesions in the proximal two-thirds of the rectum are also not reachable by TAE, leaving transabdominal resection the only curative option.[10]

Widespread use of screening programs has led to a significant increase in the detection of rectal cancers, which has propagated greater interest in developing organ-preserving techniques. Transanal endoscopic microsurgery (TEMS) was established in the 1980s as a minimally invasive procedure capable of performing full-thickness excision of rectal tumors down to the perirectal fat under general or spinal anesthesia. Current evidence supports using TEMS as a curative method for T1 rectal cancers.[11] However, in the context of more advanced rectal cancer, TEMS should only be considered a compromise and used sparingly in selected patient groups.[12]

Transanal minimally invasive surgery (TAMIS) was introduced more recently as an alternative to TEMS. TAMIS works on the same principles as TEMS but uses a slightly different platform on which to operate. As a technique, TAMIS has gained considerable international experience since its inception but remains relatively infantile compared to TEMS.[13]

Endoscopic submucosal dissection (ESD) is an endoluminal technique that can also remove lesions within the rectum and other parts of the colon. ESD is not covered in the scope of this article but is considered another viable option for treating pre-malignant and early rectal cancer, depending on locoregional experience and expertise.

Anatomy and Physiology

Register For Free And Read The Full Article
Get the answers you need instantly with the StatPearls Clinical Decision Support tool. StatPearls spent the last decade developing the largest and most updated Point-of Care resource ever developed. Earn CME/CE by searching and reading articles.
  • Dropdown arrow Search engine and full access to all medical articles
  • Dropdown arrow 10 free questions in your specialty
  • Dropdown arrow Free CME/CE Activities
  • Dropdown arrow Free daily question in your email
  • Dropdown arrow Save favorite articles to your dashboard
  • Dropdown arrow Emails offering discounts

Learn more about a Subscription to StatPearls Point-of-Care

Anatomy and Physiology

Rectal anatomy and physiology are incredibly complex, and a clear understanding of relevant landmarks, key structures, and neurovascular supply is crucial in rectal surgery.[14][15][16]

Anatomical Landmarks

The rectum is a distinct structure from the rest of the colon and bridges the last 15cm of the alimentary canal before reaching the anal orifice. The partition between the sigmoid colon and rectum is marked by the coalescence of tenia coli and loss of appendices epiploicae, normally found at the level of the sacral promontory. From an anatomical perspective, the rectum can be arbitrarily divided into three parts - upper (12 to 15 cm from the anal verge), middle (7 to 11 cm from the anal verge), and lower (up to 6cm from the anal verge). Functionally, the rectum has two parts - the upper part acting in a propulsive manner similar to the sigmoid colon. In contrast, the lower part is dilated and forms a reservoir for storage purposes.[17][18][19]

Relationship to Other Structures

The upper two-thirds of the rectum is covered in the pelvic peritoneum (continuation of parietal peritoneum), which thickens and reflects anteriorly and laterally to protect the ureters and posterior bladder in both sexes. This forms the rectovesical pouch in men and the pouch of Douglas in women. The pelvic peritoneum covers the uterus and fallopian tubes (broad ligament) before extending posteriorly over the cervix and vaginal fornix to form the rectouterine pouch.[20]

Denovillier's fascia is the rectoprostatic fascia that lies between the anterior surface of the rectum and the prostate and seminal vesicles. Within this fascia, it may be possible to identify the hypogastric nerves and small vessels supplying the male reproductive organs, although this is often not easily recognized.[21] 

Waldeyer's fascia is found on the posteroinferior side of the rectum as a thickening of the presacral fascia that descends to meet the mesorectal fascia about 3 to 5 cm from the anorectal junction. This fascia appears to act as an anchor tethering the rectum to the sacral bone.[22]

Mesorectum

The rectum is enveloped in a layer of adipose tissue known as the mesorectum, surrounded by mesorectal fascia. The mesorectum contains the descending branches of the superior rectal artery, corresponding venous tributaries, and draining lymphatics and nodes. The site of surgical dissection in total mesorectal excision lies in a relatively avascular areolar plane between the mesorectal fascia and parietal pelvic fascia.[23][24]

Neurovascular Supply

The vascular supply to the rectum comes from three main arteries - the superior rectal artery, middle rectal artery, and inferior rectal artery. The inferior mesenteric artery gives off the superior rectal artery, which supplies the upper part of the rectum and provides approximately 80% of the total blood supply. The remainder comes from the anterior division of the internal iliac artery, below the level of the pelvic floor, giving rise to the middle rectal artery and internal pudendal artery. The inferior rectal artery is a branch of the internal pudendal artery and supplies the anorectal junction, internal and external anal sphincters, and peri-anal skin.

Similar to artery supply, the venous drainage of the rectum occurs via three veins - superior, middle, and inferior rectal veins. The superior rectal vein drains into the inferior mesenteric vein as part of the portocaval system. Meanwhile, the middle and inferior rectal veins drain back into the systemic venous system via the internal iliac and internal pudendal veins, respectively. The lymphatic drainage for the upper third of the rectum follows the superior rectal vessels from the pararectal lymph nodes to the inferior mesenteric nodes. The lower aspect of the rectum drains along the middle rectal vessels directly into the internal iliac lymph nodes.[25]

The autonomic supply to the rectum is provided by sympathetic and parasympathetic systems. The sympathetic nerves reach the rectum via the lumbar splanchnic nerves and superior and inferior hypogastric plexuses. The parasympathetic supply is delivered by the pelvic splanchnic nerves (S2, S3, and S4), traveling down into the pelvis to become the inferior hypogastric plexus on either side of the rectum. The inferior hypogastric plexus is an important network of nerves that controls the function of pelvic organs. Injury to the plexus can therefore lead to significant urinary and sexual dysfunction.[26]

Indications

Transanal excision of rectal cancer is indicated for treating benign polyps or early-stage cancers in selected patients.[27] Lesions suitable for local excision are typically small (less than 3 cm in size), mobile, and involve less than a third of the rectal circumference to allow enough space to work. Larger lesions can certainly be removed using TEMS or TAMIS by an experienced surgeon, although the risk of complications would increase. If the technique is used for curative purposes in cancer, there should also be no evidence of local-regional spread, such as enlarged visible or palpable mesenteric lymph nodes. 

For malignant lesions, local excision using transanal microsurgery is accepted for T1N0 rectal cancers. T1 rectal cancers are further subdivided into sm1 (submucosal invasion of fewer than 1000 micrometers), sm2, and sm3 (submucosal invasion of greater than 1000 micrometers), depending on the depth of submucosal invasion. Nodal involvement in sm1 is 0 to 1.8% compared with 12.8 to 13.8% in sm2 or sm3, thereby significantly increasing the chance of recurrence. As a result, the European Society for Medical Oncology recommends local excision for T1 sm1 rectal cancers and rectal resection with total mesorectal excision for sm2 and sm3.[28]

Furthermore, rectal microsurgery can treat a variety of benign or premalignant lesions, including rectal polyps, solitary rectal ulcers, rectal stenosis, and prolapse.[29]

Contraindications

Transanal microsurgery is often limited by technical factors, including the location and size of the tumor. Lesions low down in the rectum (<5 cm from the anal verge) may not be easily excised due to being obscured by the transanal port. Tumors occupying >30% of the luminal circumference or >3 cm in size may also be considered contraindications, although this depends on surgeon experience. Nonetheless, if the lesion possesses one of these attributes, excision will be difficult and lead to worse oncological outcomes.[30][31]

Equipment

Transanal Endoscopic Microsurgery (TEMS)

TEM was the first rigid platform created in 1983. The proctoscope has a flat or beveled end with a diameter of 40mm and a length of 12 or 20 cm. Once introduced into the rectum, the proctoscope is sealed with a faceplate that contains multiple ports for inserting the stereoscopic optics system and surgical instruments. The stereoscopic optics system provides depth perception by allowing the surgeon to see in three dimensions. Penumorectum is maintained by an insufflation system, while a roller pump drives suction irrigation. The entire platform is secured to the operating table using a support arm.[32][33]

Transanal Minimally Invasive Surgery (TAMIS)

TAMIS was introduced in 2010 after single incision laparoscopic ports became widely available. The TAMIS platform was adapted from the SILS Port and GelPOINT PATH and incorporated a flexible port with multiple channels for the insertion of conventional laparoscopic camera scopes and instruments.[34][35]

Insufflation 

Maintaining a stable pneumorectum is essential in both TEMS and TAMIS to maintain a clear operative field and space in which to work. Generally speaking, pressures of 12 to 15 mmHg is used in rectal microsurgery. In TEMS, a multifunctional endosurgical unit regulates CO2 insufflation and suction while monitoring intrarectal pressure. Meanwhile, TAMIS uses a gel seal cap with a port that allows the insufflation of CO2. More recently, Airseal has been introduced in TAMIS, which is a tri-lumen filtered tube set that optimizes gas flow by insufflating CO2 and extracting smoke simultaneously.

Personnel

The essential theatre team is composed of the surgeon, surgical assistant, anesthesiologist, and scrub nurse. Other members may also present to help position the patient, assist in the anesthetic process and retrieve equipment intraoperatively.

Preparation

Pre-operative Work-up

The standard of care for rectal microsurgery can be variable across different centers due to a lack of uniformity and standardization. The work-up and decision-making process are the same for TEMS and TAMIS. Once a rectal lesion has been identified and considered suitable for localized surgery, a full colonoscopy should be performed to exclude any synchronous tumors elsewhere in the colon. The rectal lesion must be accurately localized, with its position and orientation carefully documented.

Staging is performed using a combination of magnetic resonance imaging and endoscopic ultrasound to characterize the lesion with computed tomography of the chest, abdomen, and pelvis to ensure there is no evidence of metastatic disease. Biopsy of the rectal lesion is a contentious topic as there is a risk of fragmentation and seeding of cancer. Furthermore, any disruption to the tissue will lead to scarring and make mucosal resection more difficult. 

Nonetheless, without histological analysis, it is difficult to appreciate the exact nature of the lesion and the extent of invasion. Transanal microsurgery can be used as a curative method for low-risk T1 (sm1) rectal cancers, but patients with poor histological features or deeper submucosal invasion (sm2 and sm3) have a high risk of recurrence.[36] Consequently, the decision to perform either an initial biopsy or proceed straight to an excision biopsy should be discussed at a multidisciplinary meeting involving surgeons, radiologists, and histopathologists. 

If the patient has been diagnosed with early rectal cancer, then cancer nurse specialists should be made available to provide patient support and detailed information about the operation and recovery. A stoma nurse consultation may also be deemed necessary to give advice and reassurance to patients even though the likelihood of a stoma is low. 

Pre-operative Preparation

Patients are typically given full bowel preparation the day before surgery to empty the bowel and provide optimal exposure and access to the tumor. Prophylactic antibiotics and venous thromboembolism prophylaxis are administered at the surgeon's discretion at the time of the procedure. 

Post-operative Care 

After the operation, patients tend to stay one or two days in the hospital. Most people will complain of discomfort or some pain in the back passage, but this should resolve quickly. Oral intake is encouraged, and although there is no consensus, solid food can usually be started immediately. Bowel movements will be quite loose initially and can take a few weeks to normalize. In certain scenarios, the patient may need the help of dieticians to adjust their dietary intake for a short period postoperatively to ensure nutritional needs are met.  

Technique or Treatment

Positioning for TEM

For the rigid platform, the patient needs to be positioned so that the lesion is 'down' relative to the angled stereoscopic optic system, which is fixed to the proctoscope with the bevelling facing downward. Depending on the location of the lesion, the patient may need to be in a prone position for anterior lesions, supine or lithotomy for posterior lesions, and right or left-sided tilt for lateral lesions. 

Positioning for TAMIS

Less positioning is required in TAMIS as the port allows for 360 degrees of movement and visualization. The patient is placed in the lithotomy position regardless of the orientation and location of the lesion. In certain circumstances, some surgeons may prefer the lithotomy position for distal and mid rectal lesions but the prone position for proximal anterior lesions.[34]

Resection

Diathermy is used to mark out a margin of 10 to 15 mm around the lesion. Dissection is typically started on the lower edge of the lesion, working superiorly in a circumferential manner. Malignant lesions require full-thickness excision of the rectal wall down to the mesorectal fat. The defect in the rectal wall is transversely closed with absorbable sutures to prevent lumenal stenosis. The specimen is orientated, kept in formalin, and sent for histological assessment. The risk of entering the peritoneal cavity is much higher for proximal anterior lesions. Perforations can generally be closed without entry into the abdomen. Full-thickness excision is typically recommended even for benign neoplasms as these lesions can harbor an invasive component.[34][37][38]

Complications

Patients who undergo local excision using rectal microsurgery generally have better functional outcomes than transabdominal procedures. Nonetheless, fecal incontinence remains a possible complication often attributed to using a large-diameter proctoscope. Other potential sequelae include post-operative rectal bleeding, proctalgia, rectal stenosis, and pelvic inflammation or abscess.

In certain cases, free perforation into the abdominal cavity may occur, leading to peritonitis and the need for major transabdominal surgery. Generally, rectal microsurgery is considered very safe and far superior in terms of hospital stay and recovery compared to traditional mesorectal excision.[39][40]

Clinical Significance

The indications, techniques, platforms, and complications of rectal microsurgery are discussed in this article. Overall awareness of different platforms and techniques enables health professionals to select patients correctly and provide adequate clinical information and aftercare for those undergoing this procedure. Recognizing normal post-operative recovery versus potential complications will also prevent unnecessary investigation or delay in diagnosis and treatment. 

Enhancing Healthcare Team Outcomes

An interprofessional approach to colorectal cancer is crucial for achieving good patient outcomes. Rectal microsurgery is an emerging technique. Knowledge of patient selection and procedural steps are essential for good postoperative care and early identification of potential complications utilizing clinicians (MDs, DOs, PAs, and NPs), nursing staff, and in some cases, pharmacists. Teamwork and open communication are necessary to establish effective communication and advancement of clinical knowledge aimed at optimizing care for patients and reducing unnecessary hospital stays. 

References


[1]

Lotfollahzadeh S, Lo D, York EA, Napoleon MA, Yin W, Elzinad N, Le J, Zhang M, Yang X, Morrissey A, Elsadawi M, Zhao Q, Schaus SE, Hansen U, Chitalia VC. Pharmacologic Manipulation of Late SV40 Factor Suppresses Wnt Signaling and Inhibits Growth of Allogeneic and Syngeneic Colon Cancer Xenografts. The American journal of pathology. 2022 Aug:192(8):1167-1185. doi: 10.1016/j.ajpath.2022.04.006. Epub 2022 Jun 13     [PubMed PMID: 35710032]


[2]

Riihimäki M, Hemminki A, Sundquist J, Hemminki K. Patterns of metastasis in colon and rectal cancer. Scientific reports. 2016 Jul 15:6():29765. doi: 10.1038/srep29765. Epub 2016 Jul 15     [PubMed PMID: 27416752]


[3]

Song EJ, Jacobs CD, Palta M, Willett CG, Wu Y, Czito BG. Evaluating treatment protocols for rectal squamous cell carcinomas: the Duke experience and literature. Journal of gastrointestinal oncology. 2020 Apr:11(2):242-249. doi: 10.21037/jgo.2018.11.02. Epub     [PubMed PMID: 32399265]


[4]

Wilkinson N. Management of Rectal Cancer. The Surgical clinics of North America. 2020 Jun:100(3):615-628. doi: 10.1016/j.suc.2020.02.014. Epub 2020 Apr 15     [PubMed PMID: 32402304]


[5]

Li R, Zhang C, Du K, Dan H, Ding R, Cai Z, Duan L, Xie Z, Zheng G, Wu H, Ren G, Dou X, Feng F, Zheng J. Analysis of Prognostic Factors of Rectal Cancer and Construction of a Prognostic Prediction Model Based on Bayesian Network. Frontiers in public health. 2022:10():842970. doi: 10.3389/fpubh.2022.842970. Epub 2022 Jun 17     [PubMed PMID: 35784233]


[6]

Perez RO, Habr-Gama A, São Julião GP, Proscurshim I, Coelho AQ, Figueiredo MN, Fernandez LM, Gama-Rodrigues J. Transanal local excision for distal rectal cancer and incomplete response to neoadjuvant chemoradiation - does baseline staging matter? Diseases of the colon and rectum. 2014 Nov:57(11):1253-9. doi: 10.1097/DCR.0000000000000215. Epub     [PubMed PMID: 25285691]

Level 2 (mid-level) evidence

[7]

Benson AB, Venook AP, Al-Hawary MM, Arain MA, Chen YJ, Ciombor KK, Cohen S, Cooper HS, Deming D, Farkas L, Garrido-Laguna I, Grem JL, Gunn A, Hecht JR, Hoffe S, Hubbard J, Hunt S, Johung KL, Kirilcuk N, Krishnamurthi S, Messersmith WA, Meyerhardt J, Miller ED, Mulcahy MF, Nurkin S, Overman MJ, Parikh A, Patel H, Pedersen K, Saltz L, Schneider C, Shibata D, Skibber JM, Sofocleous CT, Stoffel EM, Stotsky-Himelfarb E, Willett CG, Gregory KM, Gurski LA. Colon Cancer, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network : JNCCN. 2021 Mar 2:19(3):329-359. doi: 10.6004/jnccn.2021.0012. Epub 2021 Mar 2     [PubMed PMID: 33724754]

Level 1 (high-level) evidence

[8]

Keller DS, Berho M, Perez RO, Wexner SD, Chand M. The multidisciplinary management of rectal cancer. Nature reviews. Gastroenterology & hepatology. 2020 Jul:17(7):414-429. doi: 10.1038/s41575-020-0275-y. Epub 2020 Mar 12     [PubMed PMID: 32203400]


[9]

Hawkins AT, Albutt K, Wise PE, Alavi K, Sudan R, Kaiser AM, Bordeianou L, Continuing Education Committee of the SSAT. Abdominoperineal Resection for Rectal Cancer in the Twenty-First Century: Indications, Techniques, and Outcomes. Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract. 2018 Aug:22(8):1477-1487. doi: 10.1007/s11605-018-3750-9. Epub 2018 Apr 16     [PubMed PMID: 29663303]


[10]

Young DO, Kumar AS. Local Excision of Rectal Cancer. The Surgical clinics of North America. 2017 Jun:97(3):573-585. doi: 10.1016/j.suc.2017.01.007. Epub     [PubMed PMID: 28501248]


[11]

Winde G, Nottberg H, Keller R, Schmid KW, Bünte H. Surgical cure for early rectal carcinomas (T1). Transanal endoscopic microsurgery vs. anterior resection. Diseases of the colon and rectum. 1996 Sep:39(9):969-76     [PubMed PMID: 8797643]

Level 1 (high-level) evidence

[12]

Sajid MS, Farag S, Leung P, Sains P, Miles WF, Baig MK. Systematic review and meta-analysis of published trials comparing the effectiveness of transanal endoscopic microsurgery and radical resection in the management of early rectal cancer. Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland. 2014 Jan:16(1):2-14. doi: 10.1111/codi.12474. Epub     [PubMed PMID: 24330432]

Level 1 (high-level) evidence

[13]

Van den Eynde F, Jaekers J, Fieuws S, D'Hoore AM, Wolthuis AM. TAMIS is a valuable alternative to TEM for resection of intraluminal rectal tumors. Techniques in coloproctology. 2019 Feb:23(2):161-166. doi: 10.1007/s10151-019-01954-7. Epub 2019 Mar 11     [PubMed PMID: 30859349]


[14]

WALLS EW. Ano-rectal anatomy. Proceedings of the Royal Society of Medicine. 1958 Jun:51(6):425-6     [PubMed PMID: 13567687]


[15]

Zang YW, Xiang JB. [Pathologic and functional anatomy basis of intersphincteric resection]. Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery. 2019 Oct 25:22(10):937-942. doi: 10.3760/cma.j.issn.1671-0274.2019.10.007. Epub     [PubMed PMID: 31630490]


[16]

Bennett AE. Correlative anatomy of the anus and rectum. Seminars in ultrasound, CT, and MR. 2008 Dec:29(6):400-8     [PubMed PMID: 19166036]


[17]

Ikard RW. Spiral rectal valves: Anatomy, eponyms, and clinical significance. Clinical anatomy (New York, N.Y.). 2015 May:28(4):436-41. doi: 10.1002/ca.22462. Epub 2014 Sep 15     [PubMed PMID: 25220837]


[18]

Alasari S, Lim D, Kim NK. Magnetic resonance imaging based rectal cancer classification: landmarks and technical standardization. World journal of gastroenterology. 2015 Jan 14:21(2):423-31. doi: 10.3748/wjg.v21.i2.423. Epub     [PubMed PMID: 25593457]


[19]

Hui C, Baclay R, Liu K, Sandhu N, Loo P, von Eyben R, Chen C, Sheth V, Vitzthum L, Chang D, Pollom E. Rectosigmoid Cancer-Rectal Cancer or Sigmoid Cancer? American journal of clinical oncology. 2022 Aug 1:45(8):333-337. doi: 10.1097/COC.0000000000000931. Epub 2022 Jul 18     [PubMed PMID: 35848736]


[20]

Shen Y, Yang T, Zeng H, Meng W, Wang Z. Is it worthwhile to perform closure of the pelvic peritoneum in laparoscopic extralevator abdominoperineal resection? Langenbeck's archives of surgery. 2022 May:407(3):1139-1150. doi: 10.1007/s00423-021-02412-5. Epub 2022 Jan 27     [PubMed PMID: 35083567]


[21]

Stecco C, Adstrum S, Hedley G, Schleip R, Yucesoy CA. Update on fascial nomenclature. Journal of bodywork and movement therapies. 2018 Apr:22(2):354. doi: 10.1016/j.jbmt.2017.12.015. Epub 2017 Dec 27     [PubMed PMID: 29861233]


[22]

Marecik SJ, Al-Khamis A, Kochar K, Park JJ. Robotic Resection of Presacral (Retrorectal) Tumors and Waldeyer's Fascia. Diseases of the colon and rectum. 2018 Jul:61(7):e351-e352. doi: 10.1097/DCR.0000000000001118. Epub     [PubMed PMID: 29771805]


[23]

Holmer C, Benz S, Fichtner-Feigl S, Jehle EC, Kienle P, Post S, Schiedeck T, Weitz J, Kreis ME. [Transanal total mesorectal excision-a critical appraisal]. Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen. 2019 Jun:90(6):478-486. doi: 10.1007/s00104-019-0945-x. Epub     [PubMed PMID: 30911795]


[24]

Kiyomatsu T, Ishihara S, Murono K, Otani K, Yasuda K, Nishikawa T, Tanaka T, Hata K, Kawai K, Nozawa H, Yamaguchi H, Watanabe T. Anatomy of the middle rectal artery: a review of the historical literature. Surgery today. 2017 Jan:47(1):14-19     [PubMed PMID: 27260317]


[25]

Ghareeb WM, Wang X, Chi P, Wang W. The 'multilayer' theory of Denonvilliers' fascia: anatomical dissection of cadavers with the aim to improve neurovascular bundle preservation during rectal mobilization. Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland. 2020 Feb:22(2):195-202. doi: 10.1111/codi.14850. Epub 2019 Oct 16     [PubMed PMID: 31496016]


[26]

Hu XY, Jiang Z, Zhang MG, Wang XS. [Current research status on pelvic autonomic nerve monitoring in rectal cancer surgery]. Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery. 2022 Jan 25:25(1):82-88. doi: 10.3760/cma.j.cn441530-20210324-00130. Epub     [PubMed PMID: 35067038]


[27]

Smith LE, Ko ST, Saclarides T, Caushaj P, Orkin BA, Khanduja KS. Transanal endoscopic microsurgery. Initial registry results. Diseases of the colon and rectum. 1996 Oct:39(10 Suppl):S79-84     [PubMed PMID: 8831552]


[28]

Morino M, Risio M, Bach S, Beets-Tan R, Bujko K, Panis Y, Quirke P, Rembacken B, Rullier E, Saito Y, Young-Fadok T, Allaix ME, European Association for Endoscopic Surgery, European Society of Coloproctology. Early rectal cancer: the European Association for Endoscopic Surgery (EAES) clinical consensus conference. Surgical endoscopy. 2015 Apr:29(4):755-73. doi: 10.1007/s00464-015-4067-3. Epub 2015 Jan 22     [PubMed PMID: 25609317]

Level 3 (low-level) evidence

[29]

Serra-Aracil X, Mora-Lopez L, Alcantara-Moral M, Corredera-Cantarin C, Gomez-Diaz C, Navarro-Soto S. Atypical indications for transanal endoscopic microsurgery to avoid major surgery. Techniques in coloproctology. 2014 Feb:18(2):157-64. doi: 10.1007/s10151-013-1040-9. Epub 2013 Jun 28     [PubMed PMID: 23813055]

Level 2 (mid-level) evidence

[30]

Saget A, Maggiori L, Petrucciani N, Ferron M, Panis Y. Is there a limit to transanal endoscopic surgery? A comparative study between standard and technically challenging indications among 168 consecutive patients. Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland. 2015 Jul:17(7):O155-60. doi: 10.1111/codi.13000. Epub     [PubMed PMID: 25981109]

Level 2 (mid-level) evidence

[31]

Glynne-Jones R, Wyrwicz L, Tiret E, Brown G, Rödel C, Cervantes A, Arnold D, ESMO Guidelines Committee. Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of oncology : official journal of the European Society for Medical Oncology. 2018 Oct 1:29(Suppl 4):iv263. doi: 10.1093/annonc/mdy161. Epub     [PubMed PMID: 29741565]

Level 1 (high-level) evidence

[32]

Turner J, Saclarides TJ. Transanal endoscopic microsurgery. Minerva chirurgica. 2008 Oct:63(5):401-12     [PubMed PMID: 18923351]


[33]

Qi Y, Stoddard D, Monson JR. Indications and techniques of transanal endoscopic microsurgery (TEMS). Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract. 2011 Aug:15(8):1306-8. doi: 10.1007/s11605-011-1576-9. Epub 2011 Jun 7     [PubMed PMID: 21647769]

Level 2 (mid-level) evidence

[34]

Brady JT, Sprinkle S, Izfar S, Albert MR. Transanal Minimally Invasive Surgery: A Useful Technique That Continues to Evolve. Surgical technology international. 2021 Aug 11:39():137-145     [PubMed PMID: 34380172]


[35]

Devane LA, Burke JP, Kelly JJ, Albert MR. Transanal minimally invasive surgery for rectal cancer. Annals of gastroenterological surgery. 2021 Jan:5(1):39-45. doi: 10.1002/ags3.12402. Epub 2020 Oct 26     [PubMed PMID: 33532679]


[36]

Xiong X, Wang C, Wang B, Shen Z, Jiang K, Gao Z, Ye Y. Can transanal endoscopic microsurgery effectively treat T1 or T2 rectal cancer?A systematic review and meta-analysis. Surgical oncology. 2021 Jun:37():101561. doi: 10.1016/j.suronc.2021.101561. Epub 2021 Apr 2     [PubMed PMID: 33848762]

Level 1 (high-level) evidence

[37]

Altaf K, Slawik S, Sochorova D, Gahunia S, Andrews T, Kehoe A, Ahmed S, Merseyside Early Rectal Cancer Network. Long-term outcomes of open versus closed rectal defect after transanal endoscopic microscopic surgery. Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland. 2021 Nov:23(11):2904-2910. doi: 10.1111/codi.15830. Epub 2021 Aug 14     [PubMed PMID: 34288314]


[38]

Heidary B, Phang TP, Raval MJ, Brown CJ. Transanal endoscopic microsurgery: a review. Canadian journal of surgery. Journal canadien de chirurgie. 2014 Apr:57(2):127-38     [PubMed PMID: 24666451]


[39]

Tsai BM, Finne CO, Nordenstam JF, Christoforidis D, Madoff RD, Mellgren A. Transanal endoscopic microsurgery resection of rectal tumors: outcomes and recommendations. Diseases of the colon and rectum. 2010 Jan:53(1):16-23. doi: 10.1007/DCR.0b013e3181bbd6ee. Epub     [PubMed PMID: 20010345]

Level 2 (mid-level) evidence

[40]

Verseveld M, Barendse RM, Gosselink MP, Verhoef C, de Graaf EJ, Doornebosch PG. Transanal minimally invasive surgery: impact on quality of life and functional outcome. Surgical endoscopy. 2016 Mar:30(3):1184-7. doi: 10.1007/s00464-015-4326-3. Epub 2015 Jul 3     [PubMed PMID: 26139488]

Level 2 (mid-level) evidence